BetterLife Pharma OTC Stock Forecast - Simple Moving Average
| BETRF Stock | USD 0.03 0 5.71% |
BetterLife OTC Stock outlook is based on your current time horizon. We recommend always using this module together with an analysis of BetterLife Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 27th of January 2026, the value of RSI of BetterLife Pharma's share price is approaching 45 suggesting that the otc stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling BetterLife Pharma, making its price go up or down. Momentum 45
Impartial
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of BetterLife Pharma based on different types of headlines from major news networks to social media. Using BetterLife Pharma hype-based prediction, you can estimate the value of BetterLife Pharma from the perspective of BetterLife Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of BetterLife Pharma on the next trading day is expected to be 0.03 with a mean absolute deviation of 0 and the sum of the absolute errors of 0.23. BetterLife Pharma after-hype prediction price | USD 0.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BetterLife |
BetterLife Pharma Additional Predictive Modules
Most predictive techniques to examine BetterLife price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BetterLife using various technical indicators. When you analyze BetterLife charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
BetterLife Pharma Simple Moving Average Price Forecast For the 28th of January
Given 90 days horizon, the Simple Moving Average forecasted value of BetterLife Pharma on the next trading day is expected to be 0.03 with a mean absolute deviation of 0, mean absolute percentage error of 0.000024, and the sum of the absolute errors of 0.23.Please note that although there have been many attempts to predict BetterLife OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BetterLife Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
BetterLife Pharma OTC Stock Forecast Pattern
| Backtest BetterLife Pharma | BetterLife Pharma Price Prediction | Buy or Sell Advice |
BetterLife Pharma Forecasted Value
In the context of forecasting BetterLife Pharma's OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. BetterLife Pharma's downside and upside margins for the forecasting period are 0.0003 and 12.22, respectively. We have considered BetterLife Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of BetterLife Pharma otc stock data series using in forecasting. Note that when a statistical model is used to represent BetterLife Pharma otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 105.6457 |
| Bias | Arithmetic mean of the errors | 4.0E-4 |
| MAD | Mean absolute deviation | 0.0038 |
| MAPE | Mean absolute percentage error | 0.0989 |
| SAE | Sum of the absolute errors | 0.2252 |
Predictive Modules for BetterLife Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BetterLife Pharma. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BetterLife Pharma After-Hype Price Density Analysis
As far as predicting the price of BetterLife Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in BetterLife Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of BetterLife Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
BetterLife Pharma Estimiated After-Hype Price Volatility
In the context of predicting BetterLife Pharma's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on BetterLife Pharma's historical news coverage. BetterLife Pharma's after-hype downside and upside margins for the prediction period are 0.00 and 12.23, respectively. We have considered BetterLife Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
BetterLife Pharma is out of control at this time. Analysis and calculation of next after-hype price of BetterLife Pharma is based on 3 months time horizon.
BetterLife Pharma OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as BetterLife Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BetterLife Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BetterLife Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 12.19 | 0.00 | 0.00 | 13 Events / Month | 0 Events / Month | In about 13 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.03 | 0.03 | 7.98 |
|
BetterLife Pharma Hype Timeline
BetterLife Pharma is currently traded for 0.03. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. BetterLife is projected to decline in value after the next headline, with the price expected to drop to 0.03. The average volatility of media hype impact on the company price is over 100%. The price reduction on the next news is expected to be -7.98%, whereas the daily expected return is currently at 0.07%. The volatility of related hype on BetterLife Pharma is about 2.031666667E7%, with the expected price after the next announcement by competition of 0.03. The company recorded a loss per share of 0.12. BetterLife Pharma last dividend was issued on the 26th of June 2020. The entity had 1:10 split on the 26th of June 2020. Assuming the 90 days horizon the next projected press release will be in about 13 days. Check out Historical Fundamental Analysis of BetterLife Pharma to cross-verify your projections.BetterLife Pharma Related Hype Analysis
Having access to credible news sources related to BetterLife Pharma's direct competition is more important than ever and may enhance your ability to predict BetterLife Pharma's future price movements. Getting to know how BetterLife Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how BetterLife Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CUBT | Curative Biotechnology | (0.0006) | 3 per month | 11.12 | 0.06 | 27.12 | (21.35) | 76.47 | |
| GLWLF | Glow Lifetech Corp | 0.00 | 0 per month | 2.04 | 0.03 | 5.25 | (2.70) | 27.60 | |
| QNNTF | Quantum Genomics Socit | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BIXT | Bioxytran | 0.00 | 0 per month | 0.00 | (0.02) | 13.09 | (11.44) | 39.72 | |
| BZYR | Burzynski Research | 0.00 | 0 per month | 11.83 | 0.06 | 29.41 | (23.81) | 113.87 | |
| CPMV | Mosaic Immunoengineering | 0.00 | 0 per month | 13.24 | 0.03 | 51.52 | (31.03) | 106.28 | |
| PHRRF | Pharmather Holdings | 0.00 | 0 per month | 0.00 | (0.07) | 7.50 | (8.33) | 48.18 | |
| CHMMF | Chimeric Therapeutics Limited | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TXTM | Protext Mobility | 0.00 | 0 per month | 4.86 | 0.14 | 16.13 | (8.33) | 32.26 | |
| NSHSF | Nanosphere Health Sciences | 0.00 | 0 per month | 0.00 | 0.11 | 0.00 | 0.00 | 216.93 |
Other Forecasting Options for BetterLife Pharma
For every potential investor in BetterLife, whether a beginner or expert, BetterLife Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BetterLife OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BetterLife. Basic forecasting techniques help filter out the noise by identifying BetterLife Pharma's price trends.BetterLife Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BetterLife Pharma otc stock to make a market-neutral strategy. Peer analysis of BetterLife Pharma could also be used in its relative valuation, which is a method of valuing BetterLife Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
BetterLife Pharma Market Strength Events
Market strength indicators help investors to evaluate how BetterLife Pharma otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BetterLife Pharma shares will generate the highest return on investment. By undertsting and applying BetterLife Pharma otc stock market strength indicators, traders can identify BetterLife Pharma entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 0.033 | |||
| Day Typical Price | 0.033 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0) | |||
| Relative Strength Index | 45.35 |
BetterLife Pharma Risk Indicators
The analysis of BetterLife Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BetterLife Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting betterlife otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.79 | |||
| Semi Deviation | 8.5 | |||
| Standard Deviation | 11.88 | |||
| Variance | 141.24 | |||
| Downside Variance | 130.61 | |||
| Semi Variance | 72.31 | |||
| Expected Short fall | (13.10) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for BetterLife Pharma
The number of cover stories for BetterLife Pharma depends on current market conditions and BetterLife Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BetterLife Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BetterLife Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in BetterLife OTC Stock
BetterLife Pharma financial ratios help investors to determine whether BetterLife OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BetterLife with respect to the benefits of owning BetterLife Pharma security.